CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-05 | Reynolds Thomas C Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | White Christine Anna Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | Urso David M Chief Operating Officer & GC | Grant or award · Stock Option (Right to Buy) | +1,050,000 | 1,050,000 | ||
| 2021-11-22 | KANGO SUJAY Director | Grant or award · Stock Option (Right to Buy) | +58,334 | 58,334 | ||
| 2021-07-02 | Urso David M Chief Operating Officer & GC | Shares withheld for taxes | −24,825 | $2.94 | $73K | 49,281 |
| 2021-07-02 | GOLD DANIEL P PHD Chief Executive Officer | Shares withheld for taxes | −41,320 | $2.94 | $121K | 417,312 |
| 2021-07-01 | White Christine Anna Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Reynolds Thomas C Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Glover Nicholas Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Cohen Cheryl Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Clemens Kevan Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Baltic Charles V. III Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-01 | GHALIE RICHARD G Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2021-07-01 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-07-01 | Urso David M Chief Operating Officer & GC | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2021-07-01 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +855,000 | 855,000 | ||
| 2021-05-25 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise | +5,000 | $2.52 | $13K | 458,632 |
| 2021-05-25 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 675,000 |
Page 5 of 13 · 252 trades